[1]Patent:US2005/222175,2005,A1,
[2]Patent:US2005/222176,2005,A1,
[1]Patent:US2005/222175,2005,A1
[2]Patent:US2005/222176,2005,A1
Title: PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
Journal: The Journal of pharmacology and experimental therapeutics 20100801
Title: A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties.
Journal: Bioorganic & medicinal chemistry letters 20090415
Title: Transfer of gases and metabolites in the equine placenta: a comparison with other species.
Journal: Journal of reproduction and fertility. Supplement 19751001
Title: Porvasnik SL, et al. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. J Pharmacol Exp Ther. 2010 Aug;334(2):364-72.
Title: Svejda B, et al. The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer. 2010 Jun 15;116(12):2902-12.
Title: Warburton R.R., et al. Online University.